US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.8150
- +0.1250+7.40%
Trading Nov 4 14:36 ET
381.67MMarket Cap-8642P/E (TTM)
1.8400High1.7000Low2.42MVolume1.7200Open1.6900Pre Close4.30MTurnover1.27%Turnover RatioLossP/E (Static)210.29MShares2.480052wk High-11.27P/B345.54MFloat Cap0.800052wk Low--Dividend TTM190.38MShs Float31.0000Historical High--Div YieldTTM8.28%Amplitude0.2410Historical Low1.7740Avg Price1Lot Size
Akebia Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -377.38%-10.07M | -10.80%-19.43M | 68.03%-23.38M | 95.78%-2.31M | -121.20%-7.17M | 111.84%3.63M | 18.88%-17.54M | 71.08%-73.15M | 12.94%-54.68M | 160.08%33.81M |
| Net income from continuing operations | 23.20%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -139.40%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M | 9.15%-54.1M |
| Operating gains losses | ---2.33M | --423K | -16.21%-760K | ---- | ---- | ---- | ---- | -9.00%-654K | --0 | --56K |
| Depreciation and amortization | 0.03%9.41M | -0.36%9.38M | -0.19%37.63M | -0.16%9.4M | -0.18%9.41M | -0.20%9.41M | -0.20%9.41M | -0.72%37.7M | -0.36%9.42M | -0.63%9.42M |
| Other non cash items | 305.84%2.54M | 238.79%952K | 102.40%1.5M | 103.78%2.87M | -102.86%-418K | 45.15%-1.23M | -69.85%281K | -264.98%-62.62M | -552.15%-75.91M | 460.11%14.61M |
| Change In working capital | -576.86%-13.64M | -376.92%-15.15M | -1,336.38%-20.73M | -200.28%-16.21M | -107.27%-4.21M | 103.80%2.86M | -114.93%-3.18M | 98.63%-1.44M | 82.94%-5.4M | 712.71%57.89M |
| -Change in receivables | -273.96%-3.15M | -41.21%12.67M | -91.20%994K | 1.86%-16.7M | -105.14%-3.02M | 94.97%-841K | 257.24%21.55M | 147.02%11.3M | -1,329.83%-17.02M | 499.95%58.73M |
| -Change in inventory | -528.78%-14.93M | -160.35%-4.43M | -113.32%-2.54M | -148.18%-11.78M | -58.52%-1.59M | 293.33%3.48M | 240.02%7.35M | 176.51%19.09M | 136.59%24.45M | -334.35%-1M |
| -Change in prepaid assets | -142.48%-130K | -80.86%1.41M | 1,019.00%11.84M | 120.55%1.8M | -74.46%2.36M | 103.62%306K | -18.19%7.38M | 105.67%1.06M | -237.38%-8.74M | 132.62%9.24M |
| -Change in payables and accrued expense | 171.35%7.29M | 33.94%-22.55M | 58.18%-15.27M | 235.39%8.22M | 174.49%7.96M | 110.61%2.69M | -1,063.98%-34.13M | -7.95%-36.5M | 107.21%2.45M | -162.87%-10.68M |
| -Change in other current assets | 134.76%1.07M | 78.20%-613K | 75.80%-1.36M | 125.56%6.81M | -120.86%-2.3M | -145.63%-3.06M | -185.29%-2.81M | 31.54%-5.62M | -105.95%-26.65M | 1,803.11%11.02M |
| -Change in other current liabilities | -1,167.35%-3.11M | -290.44%-2.33M | -332.21%-10.65M | -125.83%-4.56M | -35.19%-7.61M | 106.01%291K | 147.53%1.22M | 105.83%4.59M | 1,570.17%17.64M | -1,626.29%-5.63M |
| -Change in other working capital | ---- | 118.59%695K | -180.32%-3.74M | --0 | --0 | --0 | -111.19%-3.74M | 155.57%4.65M | 293.66%2.47M | -124.90%-3.78M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -377.38%-10.07M | -10.80%-19.43M | 68.03%-23.38M | 95.78%-2.31M | -121.20%-7.17M | 111.84%3.63M | 18.88%-17.54M | 71.08%-73.15M | 12.94%-54.68M | 160.08%33.81M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -100.29%-114K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -93.22%-114K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---29K | --0 | --0 | --0 | --0 | --0 | --0 | -100.29%-114K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 195.50%7.64M | 215.71%18.48M | -272.67%-25.21M | -128,900.00%-1.29M | 100.15%50K | -88,788.89%-8M | -133.58%-15.97M | -89.08%14.6M | -100.02%-1K | -299.84%-32.94M |
| Net issuance payments of debt | 195.33%7.63M | 101.71%274K | 3.03%-32M | ---8M | --0 | ---8M | ---16M | ---33M | --0 | ---33M |
| Net common stock issuance | --750K | 53,017.65%18.06M | -9.80%6.79M | 671,000.00%6.71M | -20.63%50K | --0 | -99.55%34K | -91.53%7.53M | -100.02%-1K | -99.62%63K |
| Proceeds from stock option exercised by employees | --14K | --141K | -98.51%1K | --1K | --0 | --0 | --0 | --67K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10.68%40M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 195.50%7.64M | 215.71%18.48M | -272.67%-25.21M | -128,900.00%-1.29M | 100.15%50K | -88,788.89%-8M | -133.58%-15.97M | -89.08%14.6M | -100.02%-1K | -299.84%-32.94M |
| Net cash flow | ||||||||||
| Beginning cash position | -26.89%43.62M | -52.15%44.58M | -38.64%93.17M | -67.41%48.18M | -62.38%55.29M | -66.41%59.67M | -38.64%93.17M | -34.31%151.84M | -29.34%147.85M | -40.98%146.98M |
| Current changes in cash | 43.83%-2.46M | 97.14%-957K | 17.18%-48.59M | 93.42%-3.6M | -919.93%-7.12M | 85.75%-4.37M | -229.81%-33.5M | 26.01%-58.67M | 4.75%-54.68M | 102.18%868K |
| End cash Position | -25.55%41.17M | -26.89%43.62M | -52.15%44.58M | -52.15%44.58M | -67.41%48.18M | -62.38%55.29M | -66.41%59.67M | -38.64%93.17M | -38.64%93.17M | -29.34%147.85M |
| Free cash flow | -378.18%-10.1M | -10.80%-19.43M | 68.08%-23.38M | 95.78%-2.31M | -121.20%-7.17M | 111.84%3.63M | 19.31%-17.54M | 71.04%-73.27M | 12.94%-54.68M | 160.08%33.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data